Footprint Pharma ApS: Financial statements 2019
CVR: 37165174
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Footprint Pharma ApS (CVR 37165174) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -59,461 and a net result of DKK -59,461 compared with DKK -367,563 the year before. Equity in the 2019 report amounted to DKK 460,416. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -59,461
- Profit/Loss
- DKK -59,461
- Equity
- DKK 460,416
- Total Assets
- DKK 460,416
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 0 | -59 t. | -59 t. | 460 t. | - |
| 2018 | 0 | -368 t. | -368 t. | 532 t. | - |
| 2017 | 0 | -144 t. | -144 t. | 760 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Footprint Pharma ApS has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -367,563.
About Footprint Pharma ApS
Footprint Pharma ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 26 November 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named vHL Group ApS. In 2020, the company reported a gross profit of DKK -1,263 and a net result of DKK 5,851 compared with DKK -59,461 the year before. Equity in the 2020 report amounted to DKK 466,267.